StreetInsider.com Pre-Open Movers 05/03

May 3, 2007 9:18 AM EDT

StreetInsider.com Pre-Open Movers:

Hansen Medical, Inc. (Nasdaq: HNSN) 24% HIGHER; obtained FDA clearance for commercialization of the Sensei(TM) Robotic Catheter System and Artisan Control Catheter to facilitate manipulation, positioning and control of mapping catheters during electrophysiology (EP) procedures.

Q-Med (NASDAQ: QMED) 22% HIGHER; FDA's approval of PERLANE means that will receive the final purchase sum from the agreement 2003 of USD 29.1 million from the American company Medicis, which holds the rights to sell and market PERLANE in the USA and Canada

BSD Medical Corp. (Amex: BSM) 20% HIGHER; concluded an exhibition at the American Brachytherapy Society (ABS) annual conference held in Chicago, Illinois. The ABS Annual conference provides a forum for reporting developments in brachytherapy. Brachytherapy is an interstitial form of radiation, administered by placing radioactive material in the cancer. Head and neck cancers are an important application for brachytherapy, and they were one of the focuses of the meeting. BSD Medical produces systems that are designed to boost the effectiveness of brachytherapy for certain tumors by providing companion interstitial hyperthermia therapy.

MINRAD International, Inc. (AMEX: BUF) 17% HIGHER; announced it has received approval from the FDA to market Sojourn inhalation anesthetic.

YM BioSciences Inc. (AMEX: YMI) 16.2% HIGHER; announced top-line results from its randomized, placebo-controlled Phase IIb trial of AeroLEF in opioid naive patients with post-operative pain following orthopedic surgery. AeroLEF met the primary endpoint of the study, showing a statistically significant difference in SPRID4 from placebo (p=0.0194).

Axcelis Technologies (Nasdaq: ACLS) 16% LOWER; reports Q1 EPS of $0.03, 1 cent worse than estimates.(0.04) Revenues were $97.5 million vs. $97.04 million consensus. Sees Q2 EPS of $0.03-$0.07 versus the consensus of $0.09. Sees Q2 revs of $108-$118 million versus the consensus of $113.4 million.

NVE Corp (Nasdaq: NVEC) 15% HIGHER; reports Q1 EPS of $0.33, 6 cents better than estimates.(0.27) Revenues were $4.57 million vs. $4.38 million consensus.

Sirenza Micro (Nasdaq: SMDI) 14% HIGHER; reports Q1 EPS of $0.12, 2 cents better than estimates.(0.10) Revenues were $39.1 million vs. $36.97 million consensus.

JDS Uniphase (Nasdaq: JDSU) 10% LOWER; reports Q3 EPS of $0.06, 4 cents worse than estimates.(0.10) Revenues were $361.7 million vs. $346.54 million consensus. Sees Q4 revs of $325-$345M versus the consensus of $354.5M.

Smith Micro Software (Nasdaq: SMSI) 9% LOWER; reports Q1 EPS of $0.20, 3 cents better than estimates.(0.17) Revenues were $17.7 million vs. $17.52 million consensus

Andersons (Nasdaq: ANDE) 9% LOWER; reports Q1 earnings of $0.51 per share above the consensus of $0.33. Revenues came in at $409.1 million versus the consensus of $326.8 million. Sees FY07 EPS of $2.35-$2.60 versus the consensus of $2.71.

Medicis (NYSE: MRX) 8% HIGHER; said the FDA has approved the dermal filler PERLANE for implantation into the deep dermis to superficial subcutis for the correction of moderate to severe facial folds and wrinkles, such as nasolabial folds.

OM Group (NYSE: OMG) 8% HIGHER; reports Q1 earnings from continuing operations of $1.14 per share, ex-items, 30 cents better than estimates. Revenues came in at $216.2 million versus the consensus of $221.3 million.

Maxwell Technologies (Nasdaq: MXWL) 8% LOWER; reports Q1 loss of $0.25, 1 cent worse than estimates.(-.24) Revenues were $12.6 million vs. $13.83 million consensus.

Symantec (Nasdaq: SYMC) 7% HIGHER; reports Q4 EPS of $0.24, 4 cents better than estimates.(0.20) Revenues were $1.36 billion vs. $1.27 billion consensus. Sees Q1 EPS of $0.18-$0.20, versus the consensus of $0.24. Sees FY08 EPS of $1.10-$1.15 versus the consensus of $1.09. Broker upgrades

IPSCO Inc. (NYSE: IPS) 6% HIGHER; to be Acquired By SSAB for U.S. $160 Per Share

PeopleSupport (Nasdaq: PSPT) 6% LOWER; reports Q1 EPS of $0.16, 6 cents better than estimates.(0.10) Revenues were $33.6 million vs. $32.45 million consensus. Sees Q2 EPS of $0.01-$0.03 versus the consensus of $0.10. Sees Q2 revs of $31-$32 million versus the consensus of $33.72 million. Sees FY EPS of $0.27-$0.38 versus the consensus of $0.43. Sees FY07 revs of $133-$137 million versus the consensus of $140.2 million.

RealNetworks (Nasdaq: RNWK) 6% HIGHER; reports Q1 EPS of $0.22, 5 cents better than estimates.(0.17) Revenues were $129.5 million vs. $125.26 million consensus. Sees Q2 EPS of $0.04-$0.06, versus the consensus of $0.00. Sees FY EPS of $0.23-$0.25 versus the consensus of $0.22. Sees FY revs of $547-$563M versus the consensus of $550.4M.

Blackboard (Nasdaq: BBBB) 5% HIGHER; reports Q1 EPS of $0.07, 2 cents better than estimates.(0.05) Revenues were $55.3 million vs. $53.6 million consensus. Sees Q2 EPS of $0.08-$0.10, versus the consensus of $0.07. Sees FY EPS of $0.35-$0.41 versus the consensus of $0.39.

Aspreva Pharmaceuticals (Nasdaq: ASPV) 3% LOWER; reports Q1 EPS of $1.03, cents better than estimates.(0.87) Revenues were $59.3 million vs. $58.74 million consensus.

TASER (Nasdaq: TASR) 2.4% HIGHER; Jim Cramer said if conversative candidate Sarkozy wins the French Presidential election he promised to put a TASER in every police car in France

Create E-mail AlertRelated Categories

Special Reports

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?